Article

How Many Opioids Have Received ADP Designation on the Basis of Category 1 Studies Alone?

Conference|PAINWeek Conference

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

Related Videos
Related Content
NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies
April 1st 2025

NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Child with measles rash | Image Credit: © weerapat1003 - stock.adobe.com
April 1st 2025

As the Measles Outbreak Continues to Spread, Texas Hospitals Report Cases of Vitamin A Toxicity

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Pharmacist, customer or support in shop with medicine, shopping with professional help. Pharmacy, people or together for healthcare service with advice for dosage, pill information for woman with flu
March 31st 2025

Expert Q&A: Role of Pharmacists in COVID-19 Care, Prevention Continues to Evolve

Luke Halpern, Assistant Editor Corey Frederick, PharmD, BCPS, BCIDP, CPh
Magnified pathogenic Chlamydia bacteria causing several diseases - 3d illustrationImage credit: Christoph Burgstedt | stock.adobe.com
March 31st 2025

mRNA Vaccine Candidate for Chlamydia Receives FDA Grants Fast Track Designation

Kennedy Ferruggia, Assistant Editor